A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F17%3A10336342" target="_blank" >RIV/00216208:11140/17:10336342 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00669806:_____/17:10336342
Výsledek na webu
<a href="http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12506/epdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12506/epdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/jcpt.12506" target="_blank" >10.1111/jcpt.12506</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus
Popis výsledku v původním jazyce
What is known and objective: Drug-induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti-TNF therapies have been found to be associated with a lupus-like syndrome, which is clinically distinct from classical drug-induced as well as idiopathic lupus erythematosus. Case description: We describe a case of a patient with severe psoriasis, who developed muscle pain with praesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results. What is new and conclusion: Ustekinumab might be a useful treatment option for patients with a history of TNF-induced lupus-like syndrome.
Název v anglickém jazyce
A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus
Popis výsledku anglicky
What is known and objective: Drug-induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti-TNF therapies have been found to be associated with a lupus-like syndrome, which is clinically distinct from classical drug-induced as well as idiopathic lupus erythematosus. Case description: We describe a case of a patient with severe psoriasis, who developed muscle pain with praesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results. What is new and conclusion: Ustekinumab might be a useful treatment option for patients with a history of TNF-induced lupus-like syndrome.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30216 - Dermatology and venereal diseases
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Clinical Pharmacy and Therapeutics
ISSN
0269-4727
e-ISSN
—
Svazek periodika
42
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
4
Strana od-do
363-366
Kód UT WoS článku
000400023900017
EID výsledku v databázi Scopus
2-s2.0-85013074568